Jazz Pharmaceuticals (JAZZ) PT Lowered to $163 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst David Amsellem lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $163.00 (from $166.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
